{"SPADE_N_06776": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06776", "Peptide Name": "MPG", "Source": "porcine cathelicidin peptide", "Family": "", "Gene": "Not found", "Sequence": "GALFLGFLGAAGSTMGAWSQPKKKRKV", "Sequence Length": 27, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:Jurkat (IC50=15.8 µM)", "Hemolytic Activity": "RBC:IC50 ≥ 65 µM", "Cytotoxicity": "PBMC:IC50 ≥ 65 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Cysteamidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C129H208N36O32S", "Mass": 2807.32, "PI": 11.33, "Net Charge": 5, "Hydrophobicity": -0.0, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8)183228.", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32126228"}], "Frequent Amino Acids": "GAK", "Absent Amino Acids": "CDEHINOUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 13, "Polar Residues": 14, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_10677", "Similarity": 1.0, "Sequence": "GFLGAA"}, {"SPADE_ID": "SPADE_N_04905", "Similarity": 1.0, "Sequence": "PKKKRKV"}, {"SPADE_ID": "SPADE_N_06987", "Similarity": 1.0, "Sequence": "PKKKRKVALWKTLLKKVLKA"}]}}}